{"id":"https://openalex.org/W2003230050","doi":"https://doi.org/10.1111/j.1651-2227.1994.tb17742.x","title":"Does Carbamazepine Treatment Lead to a Need of Extra Vitamin D in some Mentally Retarded Children?","display_name":"Does Carbamazepine Treatment Lead to a Need of Extra Vitamin D in some Mentally Retarded Children?","publication_year":1984,"publication_date":"1984-05-01","ids":{"openalex":"https://openalex.org/W2003230050","doi":"https://doi.org/10.1111/j.1651-2227.1994.tb17742.x","mag":"2003230050","pmid":"https://pubmed.ncbi.nlm.nih.gov/6741535"},"language":"en","primary_location":{"id":"doi:10.1111/j.1651-2227.1994.tb17742.x","doi":"https://doi.org/10.1111/j.1651-2227.1994.tb17742.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1651-2227.1994.tb17742.x","pdf_url":null,"source":{"id":"https://openalex.org/S178469169","display_name":"Acta Paediatrica","issn_l":"0365-1436","issn":["0365-1436","0803-5253","1651-2227"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-2","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Paediatrica","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086261073","display_name":"Jukka Rajantie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]},{"id":"https://openalex.org/I4210101041","display_name":"Minerva Foundation","ror":"https://ror.org/0152xm391","country_code":"FI","type":"nonprofit","lineage":["https://openalex.org/I4210101041"]}],"countries":["FI"],"is_corresponding":true,"raw_author_name":"J. RAJANTIE","raw_affiliation_strings":["Rinnekoti Institute for Mentally Retarded, Espoo, the Endocrine Research Laboratory, University of Helsinki, and the Minerva Foundation, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rinnekoti Institute for Mentally Retarded, Espoo, the Endocrine Research Laboratory, University of Helsinki, and the Minerva Foundation, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052","https://openalex.org/I4210101041"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035670155","display_name":"Christel J. E. Lamberg-Allardt","orcid":"https://orcid.org/0000-0001-7326-1904","observed_orcids":["https://orcid.org/0000-0001-7326-1904"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]},{"id":"https://openalex.org/I4210101041","display_name":"Minerva Foundation","ror":"https://ror.org/0152xm391","country_code":"FI","type":"nonprofit","lineage":["https://openalex.org/I4210101041"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"C. LAMBERG\u2010ALLARDT","raw_affiliation_strings":["Rinnekoti Institute for Mentally Retarded, Espoo, the Endocrine Research Laboratory, University of Helsinki, and the Minerva Foundation, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rinnekoti Institute for Mentally Retarded, Espoo, the Endocrine Research Laboratory, University of Helsinki, and the Minerva Foundation, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052","https://openalex.org/I4210101041"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111614194","display_name":"Maija L. Wilska","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]},{"id":"https://openalex.org/I4210101041","display_name":"Minerva Foundation","ror":"https://ror.org/0152xm391","country_code":"FI","type":"nonprofit","lineage":["https://openalex.org/I4210101041"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"M. WILSKA","raw_affiliation_strings":["Rinnekoti Institute for Mentally Retarded, Espoo, the Endocrine Research Laboratory, University of Helsinki, and the Minerva Foundation, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rinnekoti Institute for Mentally Retarded, Espoo, the Endocrine Research Laboratory, University of Helsinki, and the Minerva Foundation, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052","https://openalex.org/I4210101041"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5086261073"],"corresponding_institution_ids":["https://openalex.org/I133731052","https://openalex.org/I4210101041"],"apc_list":{"value":4480,"currency":"USD","value_usd":4480},"apc_paid":null,"fwci":0.3106,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.54183927,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"73","issue":"3","first_page":"325","last_page":"328"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10277","display_name":"Vitamin D Research Studies","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10277","display_name":"Vitamin D Research Studies","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.004999999888241291,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10516","display_name":"Parathyroid Disorders and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/carbamazepine","display_name":"carbamazepine","score":1.0},{"id":"https://openalex.org/keywords/vitamin-d-deficiency","display_name":"vitamin D deficiency","score":0.9390000104904175},{"id":"https://openalex.org/keywords/vitamin-d-supplementation","display_name":"vitamin D supplementation","score":0.8299999833106995},{"id":"https://openalex.org/keywords/intellectual-disability","display_name":"intellectual disability","score":0.8040000200271606},{"id":"https://openalex.org/keywords/children","display_name":"children","score":0.5109999775886536},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.9409999847412109},{"id":"https://openalex.org/keywords/serum-calcium","display_name":"serum calcium","score":0.7080000042915344},{"id":"https://openalex.org/keywords/25-hydroxyvitamin-d","display_name":"25-hydroxyvitamin D","score":0.9990000128746033},{"id":"https://openalex.org/keywords/alkaline-phosphatase","display_name":"alkaline phosphatase","score":0.9950000047683716},{"id":"https://openalex.org/keywords/vitamin-d-metabolism","display_name":"vitamin D metabolism","score":0.6740000247955322},{"id":"https://openalex.org/keywords/institutionalized-patients","display_name":"institutionalized patients","score":0.7749999761581421}],"concepts":[{"id":"https://openalex.org/C2779253243","wikidata":"https://www.wikidata.org/wiki/Q410412","display_name":"Carbamazepine","level":3,"score":0.9801712036132812},{"id":"https://openalex.org/C3019965780","wikidata":"https://www.wikidata.org/wiki/Q183560","display_name":"Mentally retarded","level":2,"score":0.8634009957313538},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8438831567764282},{"id":"https://openalex.org/C2776940978","wikidata":"https://www.wikidata.org/wiki/Q34956","display_name":"Vitamin","level":2,"score":0.6102520823478699},{"id":"https://openalex.org/C124490489","wikidata":"https://www.wikidata.org/wiki/Q7936963","display_name":"Vitamin D and neurology","level":2,"score":0.5898125767707825},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.5723278522491455},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46607065200805664},{"id":"https://openalex.org/C2776489590","wikidata":"https://www.wikidata.org/wiki/Q183392","display_name":"Rickets","level":3,"score":0.44462504982948303},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.4124141335487366},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.40159177780151367},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3601120710372925},{"id":"https://openalex.org/C42407357","wikidata":"https://www.wikidata.org/wiki/Q521","display_name":"Physiology","level":1,"score":0.3367064595222473},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.16781306266784668},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.05869948863983154},{"id":"https://openalex.org/C138496976","wikidata":"https://www.wikidata.org/wiki/Q175002","display_name":"Developmental psychology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000469","descriptor_name":"Alkaline Phosphatase","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002112","descriptor_name":"Calcifediol","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002118","descriptor_name":"Calcium","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008607","descriptor_name":"Intellectual Disability","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010758","descriptor_name":"Phosphorus","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014807","descriptor_name":"Vitamin D","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014807","descriptor_name":"Vitamin D","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014808","descriptor_name":"Vitamin D Deficiency","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D014808","descriptor_name":"Vitamin D Deficiency","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1651-2227.1994.tb17742.x","doi":"https://doi.org/10.1111/j.1651-2227.1994.tb17742.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1651-2227.1994.tb17742.x","pdf_url":null,"source":{"id":"https://openalex.org/S178469169","display_name":"Acta Paediatrica","issn_l":"0365-1436","issn":["0365-1436","0803-5253","1651-2227"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-2","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Paediatrica","raw_type":"journal-article"},{"id":"pmid:6741535","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6741535","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta paediatrica Scandinavica","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320320878","display_name":"Minerva Foundation","ror":"https://ror.org/02rxjts25"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":10,"referenced_works":["https://openalex.org/W1969806085","https://openalex.org/W1980256657","https://openalex.org/W1990865197","https://openalex.org/W2002275067","https://openalex.org/W2016162434","https://openalex.org/W2058072375","https://openalex.org/W2065261968","https://openalex.org/W2079154870","https://openalex.org/W2139217893","https://openalex.org/W2168815871"],"related_works":["https://openalex.org/W2093137375","https://openalex.org/W2074419996","https://openalex.org/W2800421374","https://openalex.org/W3215511217","https://openalex.org/W1802656101","https://openalex.org/W2100020107","https://openalex.org/W3169838846","https://openalex.org/W2085588074","https://openalex.org/W2014934447","https://openalex.org/W2088022176"],"abstract_inverted_index":{"Biochemical":[0],"parameters":[1],"of":[2,18,56,70],"vitamin":[3,60,88],"D":[4,40,61,72,89],"metabolism":[5],"were":[6,41],"measured":[7],"in":[8,49,62,76],"late":[9],"winter":[10],"among":[11],"40":[12],"institutionalized":[13],"mentally":[14],"retarded":[15],"patients.":[16],"Twenty":[17],"them":[19],"had":[20,32],"carbamazepine":[21,81],"as":[22],"their":[23],"only":[24],"antiepileptic":[25,34],"drug,":[26],"while":[27],"the":[28,57,66],"20":[29],"remaining":[30],"patients":[31,50,64,77],"no":[33],"drugs.":[35],"Serum":[36],"calcium":[37],"and":[38,44],"25-hydroxyvitamin":[39],"significantly":[42,47],"lower":[43],"alkaline":[45],"phosphatase":[46],"higher":[48],"with":[51,59],"than":[52],"without":[53],"carbamazepine.":[54],"Supplementation":[55],"diet":[58],"carbamazepine-treated":[63],"abolished":[65],"differences.":[67],"A":[68],"possibility":[69],"hypovitaminosis":[71],"should":[73],"be":[74],"considered":[75],"on":[78],"a":[79],"long-term":[80],"therapy,":[82],"especially":[83],"if":[84],"other":[85],"risks":[86],"for":[87],"deficiency":[90],"exist.":[91]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}